The Mounjaro therapeutic dose: what it is and when you reach it

You're on 2.5 mg and wondering when it starts

It's a fair question, and almost everyone asks it. You've started Mounjaro, you're a week in, and nothing obvious has happened. That's expected. The 2.5 mg pen (which contains four weekly doses) exists because jumping straight to an active dose causes far more nausea, vomiting and gut disruption than most people would tolerate. The starter pen's job is adjustment, full stop.

Tirzepatide activates two receptors involved in appetite signalling and the way the gut empties, GIP and GLP-1. At 2.5 mg these pathways are engaged gently. By the time your prescriber moves you to 5 mg, your system has had four weeks to adapt, and the appetite-reducing effect becomes meaningfully stronger. The 5 mg dose is often where people first notice a real shift in hunger levels. Some stay there; for others it is still a stepping stone.

The NHS medicines page for tirzepatide describes the titration schedule clearly and is worth bookmarking alongside the Patient Information Leaflet that comes with your pen. Those two sources answer specific questions about storage, injection technique and what to do if you miss a dose, your prescriber and the leaflet, not general articles like this one, are the right places for that detail.

What the trial data actually shows about dose and effect

SURMOUNT-1, a 72-week phase 3 trial involving around 2,500 adults with obesity and without type 2 diabetes, tested three maintenance doses: 5 mg, 10 mg and 15 mg. The pattern was consistent, higher doses produced greater average weight loss. The 15 mg group saw approximately 20–21% average body-weight reduction; the 10 mg group around 19%; the 5 mg group around 16%. All three outperformed placebo by a significant margin. The published paper in the New England Journal of Medicine has the full figures.

What that tells you practically: 5 mg is a genuine therapeutic dose for some people, not merely a waypoint. If you reach 5 mg and your prescriber sees good progress and tolerability, there is no clinical reason to push higher automatically. Titration is about finding your therapeutic dose, the one that produces meaningful effect at a side-effect level you can live with. The licensed schedule goes up to 15 mg because that is where the ceiling was studied, not because everyone needs to reach it.

If you want a more detailed breakdown of the dose options and what each pen contains, the full Mounjaro dose guide covers this across all six strengths. And if you are curious about the tirzepatide therapeutic dose concept from a clinical angle, this page on tirzepatide's therapeutic dose goes into the pharmacology.

Why your prescriber may hold you at a dose, and why that is good news

Titration is not a ladder you must climb to the top. NICE's appraisal of tirzepatide, TA1026, frames the goal as the highest tolerated dose that produces meaningful weight loss, tolerated is doing a lot of work in that sentence. If 10 mg is working well and 12.5 mg causes persistent nausea or other side effects, staying at 10 mg is a clinically sound decision, not a failure.

Equally, if five months in there has been very little response even at the highest tolerated dose, guidelines suggest reviewing whether to continue. That review happens with your prescriber, who can look at the whole picture, how dose increases have gone, other health factors, what you're eating alongside treatment, and whether the regimen needs adjusting.

One thing people tell us they wish they had known earlier: the side effects that bother some people most often arrive after a dose increase and tend to ease within one to two weeks as the body adjusts again. Knowing that in advance makes the early days of a new dose easier to get through. If you want to understand the cost context of staying on a particular dose, this page on Mounjaro pricing in the UK gives an honest picture of what private treatment involves.

When a clinical review, not an article, is the right next step

This page can explain what therapeutic dosing means and what the evidence shows. It cannot tell you which dose is right for you, that depends on your health history, how you have responded so far, and a conversation with a prescriber who has reviewed your case properly.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, not processed by software. If you are weighing whether to start treatment or have questions about where you are in the titration schedule, our FAQs cover a lot of ground, and the weight-loss overview explains how the different licensed options compare. When you are ready, check your eligibility with a free consultation and a real clinician will review your answers the same day.